Spinal Stabilization Technologies Enrolls First U.S. Patient in Clinical Trial

December 10, 2022
By Sean Maseola

Congratulations to Spinal Stabilization Technologies on beginning their LOPAIN2 clinical trial, measuring the efficacy of the PerQdisc Nucleus Replacement Device (NRD).

Find Under: